Thabat Khatib

Title: Thabat Khatib: Innovator in Synthetic Retinoids

Introduction

Thabat Khatib is a notable inventor based in Aberdeenshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of synthetic retinoids. His work focuses on the activation of retinoic acid receptors (RAR), which play a crucial role in various biological processes.

Latest Patents

Thabat Khatib holds a patent for "Synthetic retinoids for use in RAR activation." This invention relates to compounds of formula I, which are designed for the treatment of conditions alleviated by RAR activation. The patent also encompasses pharmaceutical compounds that include these synthetic retinoids and methods for screening compounds for their therapeutic potential. The innovative compounds feature specific structural elements, including variations in the A and R groups, which enhance their efficacy.

Career Highlights

Khatib is affiliated with the University of Durham, where he continues to advance research in the field of synthetic retinoids. His work has implications for the treatment of various diseases, showcasing his commitment to improving healthcare through innovative solutions.

Collaborations

Thabat Khatib has collaborated with esteemed colleagues such as Andrew Whiting and David Chisholm. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.

Conclusion

Thabat Khatib's contributions to the field of synthetic retinoids exemplify the impact of innovative research on healthcare. His patent and ongoing work at the University of Durham highlight the importance of scientific advancements in treating diseases through targeted receptor activation.